Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Bone Neoplasms × Etoricoxib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Bone Neoplasms 1

Interventions

Gemcitabine 3 Docetaxel 3 3-(5-fluorobenzofuran-3-yl)-4-(5-methyl-5H-(1,3)dioxolo(4,5-f)indol-7-yl)-pyrrole-2,5-dione 2 Radiotherapy 1 Radiation 1 Ibandronic Acid 1 Grafton demineralized bone matrix gel 1 Etoricoxib 1 Duration of Therapy 1 Drug Therapy 1 Cryotherapy 1 Cryosurgery 1 Anesthesia, Epidural 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00095017 2022-02-16

Safety and Efficacy of an Investigational Drug Versus Placebo in the Treatment of Cancer Pain (0663-083)

Organon and Co

Phase 2 Withdrawn

Bone Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡